Всего подписок: 0, всего просмотров: 134
Оценка читателей: голосов 0
1. Abramson H. LSD in Psychotherapy and Alcoholism // American Journal of Psychotherapy. 1966. Vol. 20 (3). P. 415—438.
2. Alper K. Fatalities Temporally Associated with the Ingestion of Ibogaine // Journal of Forensic Science. Vol. 57 (2). P. 398—412.
3. Alper K. The Ibogaine Medical Subculture // The Journal of Ethnopharmacology. 2008. Vol. 115 (1). P. 9—24.
4. Becker D. Ibogaine: One Man’s Journey to Mexico for Psychedelic Addiction Treatment // WBUR. 10 September 2018 [Электронный ресурс]. URL: https://www.wbur.org/news/2018/09/10/ibogaine-psychedelic-opioid-misuse-therapy (дата обращения: 02.02.2022).
5. Braun T. Treatment of Opioid Use Disorder with Ibogaine: Detoxification and Drug Use Outcomes // The American Journal of Drug and Alcohol Abuse. 2017. P. 24—36.
6. Buonomo T. Middle East Science Diplomacy Focused on Psychedelics Could Generate Peace Dividends // Psychedelics Today. 23 November 2020 [Электронный ресурс]. URL: https://psychedelicstoday.com/2020/11/23/middle-east-science-diplomacy-focused-on-psychedelics-could-generate-peace-dividends/ (дата обращения 02.01.2022).
7. Camnaji E. ALCE, el Sueño de la Conquista Latinoamericana del Espacio // El Pais. 21 Novembre 2020 [Электронный ресурс]. URL: https://elpais.com/mexico/2020-11-21/alce-el-sueno-de-la-conquista-latinoamericana-del-espacio.html (дата обращения: 02.02.2022).
8. Carnicella S., Ron D. GDNF — A Potential Target to Treat Addiction // Pharmacological Therapy. 2009. Vol. 122 (1). P. 9—18.
9. Comisión de Salud Fronteriza México-Estados Unidos. ¿Quiénes somos? Tijuana: Comisión de Salud Fronteriza México-Estados Unidos [Электронный ресурс]. URL: https://saludfronterizamx.org/quienes-somos/ (дата обращения: 02.02.2022).
10. DEA. Scheduling of 3,4-Methylenedioxymethamphetamine (MDMA) into Schedule I of the Controlled Substances Act // Schedules of Controlled Substances. Remand. 1988. Vol. 53 (34).
11. Doblin R. A Clinical Plan for MDMA (“Ecstasy”) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA // Journal of Psychoactive Drugs. 2002. Vol. 34 (2). P. 185—194.
12. Drug Scheduling // DEA [Электронный ресурс]. URL: https://www.dea.gov/drug-information/drug-scheduling (дата обращения: 02.02.2022).
13. Fedoroff N. Science Diplomacy in the 21st Century // Cell. Vol. 136 (1). P. 9—11.
14. Feilding A. The Man who Mapped LSD // OUPBlog. 12 February 2019 [Электронный ресурс]. URL: https://blog.oup.com/2019/02/man-mapped-lsd/ (дата обращения: 02.02.2022).
15. Fernandez J. Returning to the Path”: the Use of Iboga[ine] in an Equatorial African Ritual Context and the Binding of Time, Space, and Social Relationships // The Alkaloids: Chemistry and Biology. 2001. Vol. 56. P. 235—247.
16. Financial Reports // MAPS [Электронный ресурс]. URL: https://maps.org/fiscal/ (дата обращения: 11.02.2022).
17. Gasser P., Holstein D., Michel Y. Safety and Efficacy of LSD-ssisted Psychotherapy in Subjects with Anxiety Associated with Life-threatening Diseases: a Randomized Active Placebo-controlled Phase 2 Pilot Study // The Journal of Nervous and Mental Disease. 2014. Vol. 202 (7). P. 513—520.
18. Gasser P. Research Update: Psychedelic Group Therapy in Switzerland // MAPS Bulletin Spring 2017: Vol. 27. No. 1. Special Edition: Psychedelic Science. 2017 [Электронный ресурс]. URL: https://maps.org/news/bulletin/research-update-psychedelic-group-therapy-in-switzerland/ (дата обращения: 02.02.2022).
19. Gillmor D. I Swear by Apollo: Dr. Ewen Cameron and the CIA-brainwashing Experiments. Eden Press, 1987.
20. Ginsbert N. Early Reflections on Interviews with Palestinians and Israelis Drinking Ayahuasca Together // MAPS Bulletin Winter. Vol. 29 (3). 2019 [Электронный ресурс]. URL:https://maps.org/news/bulletin/can-psychedelics-play-a-role-in-making-peace-and-healing-cycles-of-trauma/ (дата обращения: 02.02.2022).
21. Grinspoon L., Bakalar J. Can Drugs Be Used to Enhance the Psychotherapeutic Process? // American Journal of Psychotherapy. 1986. Vol. 40 (3). P. 393—404.
22. Grof S, Halifax J, Kübler-Ross E. The Human Encounter with Death. N. Y.: EP Dutton, 1978.
23. Ibogaine. Proceedings of the First International Conference / ed. Alper K. California. Academic press. 2001.
24. Instituto de los Mexicanos en el Exterior. ¿Qué hasemos? Mexico: Instituto de los Mexicanos en el Exterior [Электронный ресурс]. URL: https://www.gob.mx/ime/que-hacemos (дата обращения: 02.02.2022).
25. Israel Approves Clinical Trial to Treat PTSD with MDMA // YouTube [Электронный ресурс]. URL: https://www.youtube.com/watch?v=3BnG8QkTO7M&ab_channel=i24NEWSEnglish (дата обращения: 02.01.2022).
26. Koenig X., Hilber K. The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation // Molecules. 2015. Vol. 20 (2). P. 2208—2228.
27. Liester M. A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects // Curriculum of Drug Abuse Review. 2014. Vol. 7 (3). P. 146—156.
28. LSD & Psilocybin-Assisted Therapy for Anxiety // MAPS. 2012 [Электронный ресурс]. URL: https://web.archive.org/web/20120414113729/http://www.maps.org/research/psilo-lsd/ (дата обращения: 11.02.2022).
29. MAPS Bulletin [Электронный ресурс]. URL: https://maps.org/maps-bulletin/ (дата обращения: 11.02.2022)
30. MAPS Public Benefit [Электронный ресурс]. URL: https://mapspublicbenefit.com/ (дата обращения: 11.02.2022).
31. Marlow J. Could Science Diplomacy Help Israel Create a Lasting Peace? // Wired. 23 November 2012 [Электронный ресурс]. URL: https://www.wired.com/2012/11/could-science-diplomacy-help-israel-create-a-lasting-peace/ (дата обращения 02.01.2022).
32. Montgomery K. Anticipatory Science Diplomacy: An interview with Ambassador Pitteloud // AAAS. 30 September 2021 [Электронный ресурс]. URL: https://www.aaas.org/news/anticipatory-science-diplomacy-interview-ambassador-pitteloud (дата обращения: 14.02.2022).
33. Naftulin J. Oregon has Become the First State to Legalize “Magic” Mushrooms for Therapeutic Use. Here’s What That Means // Insider. 5 November 2020 [Электронный ресурс]. URL: https://www.businessinsider.com/oregon-first-ever-state-to-legalize-psilocybin-for-therapeutic-use-2020-11 (дата обращения: 24.12.2021).
34. New Frontiers of Science Diplomacy // AAAS, Royal Society. 2009 [Электронный ресурс]. URL: https://royalsociety.org/~/media/royal_society_content/policy/publications/2010/4294969468.pdf (дата обращения: 02.02.2022).
35. Nichols D. Differences between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens — Identification of a New Therapeutic Class: Entactogens // Journal of Psychoactive Drugs. 1986. Vol. 18 (4). P. 305—313.
36. Nichols D. Hallucinogens // Pharmacological Therapy. 2004. Vol. 101 (2). P. 131—181.
37. Osmond H. A Review of The Clinical Effects of Psychotomimetic Agents // Annals of NY Academy of Science. 1957. Vol. 66 (3). P. 418—434.
38. Parrott A. The Potential Dangers of Using MDMA for Psychotherapy // Journal of Psychoactive Drugs. 2014. Vol. 46 (1). P. 37—43.
39. Peter Gasser: Psychedelic Psychotherapy in Switzerland // YouTube [Электронный ресурс]. URL: https://www.youtube.com/watch?v=rDFbMUdB_pU&ab_channel=N%C3%A4tverketf%C3%B6rpsykedeliskvetenskap (дата обращения: 02.01.2022).
40. PREPFAR World Activities. 2011 [Электронный ресурс]. URL: https://web.archive.org/web/20130217193723/https://hiu.state.gov/Products/Worldwide_PepfarPlans_2012July19_HIU_U568.pdf (дата обращения: 11.02.2022).
41. Reich P. Switzerland: Government Adopts a Partial Revision of the Chemicals Control Ordinance // Baker & McKenzie’s. 19 January 2022 [Электронный ресурс]. URL: https://www.globalcompliancenews.com/2022/01/19/switzerland-government-adopts-a-partial-revision-of-the-chemicals-control-ordinance-05012022/ (дата обращения: 02.02.2022).
42. Roy A. United States: No. 4 in the 2020 World Index of Healthcare Innovation // FREOP. 5 September 2020 [Электронный ресурс]. URL: https://freopp.org/united-states-health-system-profile-4-in-the-world-index-of-healthcare-innovation-b593ba15a96 (дата обращения: 02.02.2022).
43. Soler M. Science Diplomacy in Latin America and the Caribbean: Current Landscape, Challenges, and Future Perspectives // Frontiers in research metrics and analytics.
44. Strozier C., Terman D., Jones J., Boyd K. The Fundamentalist Mindset: Psychological Perspectives on Religion, Violence, and History. Oxford, 2010.
45. The HEARTS Initiative is Launched in Mexico // PAHO. 18 February 2020 [Электронный ресурс]. URL: https://www.paho.org/en/news/18-2-2020-hearts-initiative-launched-mexico (дата обращения: 02.02.2022).
46. The Royal Society. New Frontiers in Science Diplomacy. Report of the Meeting Hosted by the Royal Society from 1—2 June 2009. January 2010. P. 9.
47. United States-Israel Binational Science Foundation (BSF) [Электронный ресурс]. URL: https://www.bsf.org.il/ (дата обращения 02.01.2022).
48. Vorbrüggen M., Baer H. Humiliation: The Lasting Effect of Torture // Military Medicine. 2007. Vol. 172 (2). P. 29—33.
49. White C. 3,4-Methylenedioxymethamphetamine’s (MDMA’s) Impact on Posttraumatic Stress Disorder // Annals of Pharmacotherapy. 2014. Vol. 48 (7). P. 908—915.
50. Zendo Project [Электронный ресурс]. URL: https://zendoproject.org/ (дата обращения 11.02.2022).
51. Гризе П., Заботкина В. И., Руффини П., Чубарьян А. О. Научная дипломатия: теория и практика // Электронный научно-образовательный журнал «История». 2021. T. 12. Выпуск 12 (110). Часть II. URL: https://history.jes.su/s207987840018743-6-1/ DOI: 10.18254/S207987840018743-6
52. Киселев В. Новое измерение научной дипломатии // РСМД. 15 декабря 2017 [Электронный ресурс]. URL: https://russiancouncil.ru/analytics-and-comments/analytics/novoe-izmerenie-nauchnoy-diplomatii/?sphrase_id=87925645 (дата обращения: 22.02.2022).